C1332774||COL4A3 (rs55703767)
C1334523||MMP-9 (rs17576)
C1367459||TIMP-1 (rs6609533)
C0012655||susceptibility
C0011860||type 2 diabetes
C0011860||Type 2 diabetes
C0011860||Type 2 diabetes
C0428548||levels of glucose
C0005767||blood
C0009333||collagen IV
C0020456||hyperglycemia
C0021655||insulin resistance
C1314894||Collagen type IV Î±3 chain (COL4A3)
C0582263||structural protein
C0015350||extracellular matrix
C0015350||extracellular matrix
C0165519||Matrix metallopeptidase 9
C0165519||Matrix metallopeptidase 9
C0014442||enzyme
C0015350||extracellular matrix
C0243102||activity
C0145947||TIMP metallopeptidase inhibitor 1
C0145947||TIMP metallopeptidase inhibitor 1
C0032529||genetic polymorphisms
C1332774||COL4A3 (rs55703767)
C1334523||MMP-9 (rs17576)
C1367459||TIMP-1 (rs6609533)
C0011860||Type 2 diabetes
C0007328||case-control study
C1553355||Iranian
C0011860||Type 2 diabetes
C0237401||healthy individuals
C2732542||analyzed using the amplification refractory mutation system-polymerase chain reaction technique
C0002085||allelic
C1332774||COL4A3
C0018321||G
C0040087||T
C1334523||Matrix metallopeptidase 9
C0001407||A
C0018321||G
C1332774||COL4A3
C0018321||G
C0040087||T
C0040087||TT
C0018321||GG
C0040087||T
C0018321||G
C1334523||Matrix metallopeptidase 9
C0001407||A
C0018321||G
C0001407||A
C0018321||G
C0018321||GG
C0001407||A
C0018321||G
C1367459||TIMP metallopeptidase inhibitor 1
C0001407||A
C0018321||G
C0011860||Type 2 diabetes
C0043210||females
C0025266||males
C0002085||allelic
C1332774||COL4A3
C0018321||G
C0040087||T
C1334523||Matrix metallopeptidase 9
C0001407||A
C0018321||G
C0011860||Type 2 diabetes
C1367459||TIMP metallopeptidase inhibitor 1
C0001407||A
C0018321||G
C0017337||gene
C0043210||females
C0025266||males
C0015031||ethnic groups